Skip to main content
Bioton S.A. logo

Bioton S.A. — Investor Relations & Filings

Ticker · BIO ISIN · PLBIOTN00029 LEI · 259400I5R1L3OPCGII81 WAR Manufacturing
Open in API
Filings indexed 697 across all filing types
Latest filing 2021-10-29 Interim / Quarterly Rep…
Country PL Poland
Listing WAR BIO

About Bioton S.A.

https://bioton.com/en/

Bioton S.A. is a biotechnology company focused on providing comprehensive solutions for diabetes care. The company's core activity is the development and production of recombinant human insulin, positioning it as a significant commercial manufacturer globally. Its operations cover the full biotechnological process, from DNA research and development to the manufacturing and marketing of finished medicinal products. The product portfolio is centered on various forms of insulin and is complemented by modern automatic injection systems designed to facilitate effective diabetes treatment for patients.

Recent filings

Filing Released Lang Actions
Informacja dodatkowa do raportu Q3
Interim / Quarterly Report Classification · 100% confidence The document is a detailed quarterly financial report for the BIOTON S.A. Group for the third quarter of 2021. It contains comprehensive financial data, including income statements, balance sheets, segment reporting, and accounting principles. It is not an announcement of a report (RPA) or a simple regulatory filing (RNS), as it provides substantive financial analysis and tables for the specified period. Therefore, it is classified as an Interim/Quarterly Report. 9M 2021
2021-10-29 Polish
Sprawozdanie finansowe Q3
Interim / Quarterly Report Classification · 100% confidence The document is a 'Skonsolidowany rozszerzony raport kwartalny' (Consolidated Extended Quarterly Report) for the period ending September 30, 2021. It contains detailed financial statements, including the Consolidated Income Statement, Consolidated Balance Sheet, and Statement of Comprehensive Income. As it provides comprehensive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. 9M 2021
2021-10-29 Polish
Wniesienie przez AIS Investment 2 Sp. z o.o. skargi kasacyjnej - Content (PL)
Legal Proceedings Report Classification · 98% confidence The document text is a formal announcement from the Management Board of Bioton S.A. regarding the receipt of a cassation appeal (skarga kasacyjna) against a previous court ruling concerning a transaction (sale of SciGen Ltd). This content directly relates to ongoing significant legal matters and lawsuits involving the company. Based on the definitions, this fits best under 'Legal Proceedings Report' (LTR), which covers updates on significant lawsuits and regulatory actions. The document is short and appears to be a regulatory disclosure rather than a full legal filing or report.
2021-09-09 Polish
wybrane jednostkowe dane 1H 2021
Earnings Release Classification · 99% confidence The document provided consists entirely of structured financial data tables, specifically presenting 'WYBRANE DANE FINANSOWE' (Selected Financial Data) for BIOTON S A, covering comparative periods (H1 2020 vs H1 2021) in both PLN and EUR. It includes key line items like Net Sales Revenue, Net Profit/Loss, Cash Flows, Balance Sheet totals, and per-share metrics (EPS, Book Value). This format strongly suggests a detailed financial statement extract or a data supplement, rather than a narrative report (like 10-K or IR) or a brief announcement (like ER or RPA). Given the comprehensive nature of the data presented in tables, it aligns best with the content typically found in a detailed financial filing or a data supplement. Since there is no explicit mention of an accompanying narrative report or a specific regulatory form number (like 10-K), and the data is highly structured, it most closely resembles the content provided in a Financial Supplement Data (XLSX) or perhaps an Interim Report (IR) if this were the core data section. However, the structure, focusing purely on comparative numbers without narrative context, is highly characteristic of data intended for direct analysis or spreadsheet import. Comparing the options: - 10-K/IR: These usually contain extensive narrative sections (MD&A, footnotes). This document is purely data tables. - ER: Too detailed for a typical Earnings Release. - FS (Fund Factsheet): Usually much shorter and less granular. - XLSX (Financial Supplement Data): This category is defined as 'Supplementary financial data provided in a detailed Excel spreadsheet format.' Although this is presented as text, the content is exactly what one would find in such a supplement. Given the highly structured, comparative, and purely numerical nature of the content, 'Financial Supplement Data' (XLSX) is the most appropriate classification for this data dump, even though it's presented in markdown tables rather than an actual XLSX file. H1 2021
2021-08-31 Polish
wybrane skonsolidowane dane 1H 2021
Earnings Release Classification · 99% confidence The document presents 'SKONSOLIDOWANE DANE WYBRANE DANE FINANSOWE' (Consolidated Selected Financial Data) for BIOTON S.A., comparing two semi-annual periods (01.01.2020 - 30.06.2020 and 01.01.2021 - 30.06.2021) and providing balance sheet data as of the end dates (30.06.2021 and 31.12.2020). It includes key line items like Net Sales Revenue, Gross Profit, Net Profit, Cash Flows, and per-share metrics. This structure strongly indicates a comprehensive financial report covering a period shorter than a full year, which aligns with the definition of an Interim/Quarterly Report (IR). It is not a brief announcement (RPA/ER) but detailed financial statements/data. H1 2021
2021-08-31 Polish
Raport biegłego rewidenta 1H 2021 jednostkowe
Audit Report / Information Classification · 100% confidence The document is a 'Report of the Independent Auditor on the Review of the Interim Condensed Financial Statements' (Raport niezależnego biegłego rewidenta z przeglądu śródrocznego skróconego sprawozdania finansowego). It is a standalone audit review report for the period ending June 30, 2021, for Bioton S.A. According to the filing definitions, standalone audit reports and results of regulatory reviews (excluding the full annual report) fall under the 'AR' (Audit Report / Information) category. H1 2021
2021-08-31 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.